20 states. Could a federally mandated pay raise be next . And remembering 2014. The stories that matter the most last year. And the issues that will certainly make headlines through the next. We begin tonight with bittersweet news they have been in an egyptian prison for over a year. It is raising hopes that convictions can be overturned. Roxanne that has the latest jonathon the state Department Says it will keep urging egypt to release the journalists. Obviously we welcome the courts recognition that the original decision was flawed even as we remain concerned. We believe that all journalists have a right to do their jobs, free from intimidation or fear of retribution. Many supporters say they never should have been arrested in the first place. After a full year in prison, the three al jazeera journalists start the new year behind bars. On thursday, the top Court Ordered a retrial for australian peter greste, and canadian egyptian Mohamed Fahmy. Its hard to see your loved one in priso
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And s
Headquarters in london. I am mark barton. And i am Olivia Sterns. We begin in ukraine. Lets get straight to ryan chilcote. Ighting continues to rage both sides stepping up their attack. Ryan is in kiev with the latest read it looks like the country is seeing some of the deadliest violence and the crisis began. What is the latest you are hearing on the ground . Good morning. The Ukrainian Government says they are going to push on with the fighting in the east of the country. The death toll from yesterdays battles stands at 40. All of those on the rebel side. It includes russian nationals. You will remember that several dozen russian fighters came from russia itself into eastern and identified themselves as chess champ chechaners volunteers. If they were, they were there on their own private business. Clearly, this is becoming a very messy affair. Lots of collateral damage. An additional 31 people injured. , which the Ukrainian Government did capture, was also damaged, so it remains clos
Grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cash and stock offer is too low and that it undervalues the company. We took a look at what combining these two companies mean to the pharmaceutical industry and whats at stake for pfizer and astrazeneca. Its the kind of deal that doesnt come around too often. 14 years ago pfizer paid 85 billion to buy warner lambert. That was the Biggest Health care combination ever. And since the recession theres b